What is the appropriate SOAP note for a 17‑year‑old male undergoing a pre‑participation physical for Junior Reserve Officer Training Corps (JROTC), who has a history of intermittent asthma well‑controlled with no exacerbations in the past two years and uses a short‑acting β2‑agonist (albuterol) inhaler only as needed?

SOAP Note for 17-Year-Old JROTC Physical with Well-Controlled Intermittent Asthma

This patient has well-controlled intermittent asthma requiring only as-needed albuterol, which is appropriate for JROTC participation with proper documentation and inhaler technique verification.

Subjective

Chief Complaint: Pre-participation physical examination for Junior Reserve Officer Training Corps (JROTC)

History of Present Illness:

• 17-year-old male presenting for JROTC physical clearance
• History of asthma, currently well-controlled
• No exacerbations or symptoms requiring intervention in past 2 years
• Uses albuterol inhaler only as needed (PRN) for symptom relief
• Frequency of albuterol use: Document specifically if using less than 2 days per week for symptom relief (not counting pre-exercise prophylaxis), as this indicates good control per NAEPP guidelines 1
• No nocturnal awakenings due to asthma
• No limitation of activities or exercise intolerance
• No recent oral corticosteroid use
• No emergency department visits or hospitalizations for asthma

Review of Systems:

• Respiratory: Denies current wheezing, shortness of breath, chest tightness, or cough
• Constitutional: Denies fever, weight loss
• Cardiovascular: Denies chest pain, palpitations, syncope with exercise

Objective

Vital Signs: Document heart rate, blood pressure, respiratory rate, oxygen saturation

Physical Examination:

• General: Well-appearing, no acute distress
• Respiratory:
  • Clear to auscultation bilaterally
  • No wheezing, rales, or rhonchi
  • Normal respiratory effort, no accessory muscle use
  • No chest wall deformities
• Cardiovascular: Regular rate and rhythm, no murmurs
• HEENT: No nasal polyps, no allergic shiners

Inhaler Technique Assessment: Critical to observe and document proper metered-dose inhaler (MDI) technique, as many patients demonstrate inadequate technique 1. Verify patient can:

• Shake inhaler before use
• Exhale fully before actuation
• Coordinate actuation with slow, deep inhalation
• Hold breath for 10 seconds post-inhalation

Assessment

Well-controlled intermittent asthma (based on NAEPP EPR-3 classification 1):

• Symptoms ≤2 days/week
• No nighttime awakenings
• No interference with normal activity
• SABA use ≤2 days/week
• No exacerbations requiring oral corticosteroids in past 2 years

Medically cleared for JROTC participation with the following considerations:

• Current asthma control meets criteria for unrestricted physical activity
• As-needed SABA use is appropriate for this level of control 1
• No indication for daily controller therapy at this time, as patient meets criteria for intermittent asthma

Plan

1. Medication Management

• Continue albuterol MDI as needed for symptom relief or pre-exercise prophylaxis 1
• Standard dosing: 2 puffs every 4-6 hours as needed 1
• Pre-exercise use: May use 2 puffs 5-15 minutes before anticipated exercise to prevent exercise-induced bronchoconstriction 2, 3
• Reinforce: If albuterol use increases to >2 days per week (excluding pre-exercise prophylaxis), patient should return for reassessment as this indicates inadequate control and need for daily controller therapy 1, 4

2. Education and Self-Management

• Reviewed proper MDI technique with patient today—document specific technique observed 1
• Provide written asthma action plan including:
  • When to use rescue inhaler
  • Warning signs of worsening asthma (increased SABA use, nocturnal symptoms, activity limitation)
  • When to seek urgent medical care
• Trigger avoidance: Identify and avoid known asthma triggers (allergens, cold air, respiratory infections) 4
• Ensure patient carries rescue inhaler at all times, especially during JROTC activities

3. JROTC-Specific Considerations

• Medical clearance: Patient is cleared for full participation in JROTC physical activities
• Advise patient to inform JROTC instructors of asthma diagnosis and location of rescue inhaler
• Patient should have immediate access to albuterol during all physical training
• May use albuterol prophylactically before strenuous exercise 2, 3

4. Monitoring and Follow-Up

• Routine follow-up in 6-12 months or sooner if:
  • Increased frequency of symptoms or SABA use
  • Any nocturnal awakenings due to asthma
  • Any limitation of activities
  • Any exacerbation requiring oral corticosteroids
• Urgent evaluation needed if: Symptoms worsen despite appropriate SABA use, or if experiencing severe exacerbation symptoms (severe dyspnea, inability to speak in full sentences, chest tightness not relieved by albuterol) 5

5. Prescription

• Albuterol sulfate MDI 90 mcg/actuation
• Dispense: 1 inhaler (200 actuations)
• Sig: Inhale 2 puffs every 4-6 hours as needed for wheezing, shortness of breath, or chest tightness; may use 2 puffs 5-15 minutes before exercise
• Refills: 3

---

Key Clinical Pitfall to Avoid: The critical threshold is SABA use >2 days per week for symptom relief (not counting pre-exercise prophylaxis). If this threshold is crossed, the patient has progressed from intermittent to mild persistent asthma and requires initiation of daily low-dose inhaled corticosteroid therapy 1, 4. Regular monitoring of SABA frequency is essential to detect this transition early and prevent exacerbations.